YMRC
BNTX icon

Yorktown Management & Research Company’s BioNTech BNTX Stock Holding History

Yorktown Management & Research Company’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,750
Closed -$218K – 201
2023
Q1 		$218K Hold
1,750
– – 0.24% 185
2022
Q4 		$263K Buy
+1,750
New +$269K 0.32% 157

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
AGA
Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Yorktown Management & Research Company's BNTX Position: Q2 2023 in Review

Yorktown Management & Research Company sold out of BioNTech (BNTX) in Q2 2023, closing a stake of 1,750 shares — an estimated $218K sold.

Yorktown Management & Research Company first reported a position in BNTX in Q4 2022 and held it in 2 quarters. The position peaked at $263K in Q4 2022. 253 funds tracked by Wall St. Rank hold BNTX as of Q2 2023.

  • Yorktown Management & Research Company reported no remaining BioNTech position as of Q2 2023 after selling out during the quarter.
  • Yorktown Management & Research Company sold 1,750 BioNTech shares in Q2 2023, an estimated $218K.
  • Yorktown Management & Research Company first reported a position in BioNTech in Q4 2022 and held it in 2 quarters.
  • Yorktown Management & Research Company's BioNTech position peaked at $263K in Q4 2022.
  • 253 funds tracked by Wall St. Rank held BioNTech as of Q2 2023.

Based on Yorktown Management & Research Company's 13F filing for Q2 2023, filed 28 Jul 2023.